Dysregulation of lipoprotein metabolism in the metabolic syndrome may be due to a combination of overproduction of very-low density lipoprotein (VLDL) ApoB, decreased catabolism of ApoB-containing particles, and increased catabolism of HDL-ApoAI particles. This evidence concerns the gene APOA1 and metabolic syndrome.